Business Wire

LEAPMOTOR

28.6.2022 14:02:14 CEST | Business Wire | Press release

Share
Leapmotor's 100,000th Mass-Produced Vehicle Rolls off the Line

Today, Leapmotor's 100,000th mass-produced vehicle rolled off the line. On June 28, 2019, Leapmotor's first mass-produced vehicle, S01, rolled off the line. It took three years from S01 to C11 (the 100,000th mass-produced vehicle), realizing the leap from 0 to 100,000 in the field of intelligent EV. And it only took half a year to reach 100,000 vehicles from 50,000.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220628005686/en/

Zhu Jiangming, the Founder and Chairman of Leapmotor, said in a thank-you letter that seven years witnessed Leapmotor's winning the trust of 100,000 users. In addition to gratitude, Leapmotor will go forward with more friends by adhering "guard against arrogance, and consistency in original aspiration". We will continue to make breakthroughs and innovation in the core technology field, and focus on the user-centered concept to keep moving with our users, thus delivering the finest smart mobility experience to all consumers.

After seven years of independent full-suite of R&D, the Leapmotor has ushered in a phenomenal development in 2022:

In March, the monthly delivery volume of Leapmotor vehicles exceeded the threshold of 10,000 units for the first time;
In April, launched the first mass-produced model with CTC technology in China - Released the integrated technology of battery chassis of Leapmotor intelligent power CTC;
In May, Leapmotor C01, the electric vehicle equipped with CTC technology without battery pack, launched a pre-sale, and the current order has reached 60000 units; at the same time, the delivery volume reached a new high in May, achieving a year-on-year growth of more than 200% for 14 consecutive months;
In June, the 100,000th mass-produced vehicle was off the production line.

Leapmotor independently controls the core technology. Since 2015, Leapmotor has established a short-term difficult but long-term correct route of full-suite of R&D, striving to build the core competitiveness of technological innovation, which has greatly enhanced Leapmotor's ability to resist external risks under uncertain factors.

Moreover, in order to cope with the uncertainty of the supply chain, Leapmotor also made a layout in advance, built the mechanism of multi supply enterprises and multi-regional planning, and effectively improved the ability of the supply chain to resist risks.

With the further innovation and improvement of Leapmotor product matrix, Leapmotor will brave winds and waves and continue to deliver the finest smart mobility experience to all consumers.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Inside Moutai House Singapore: Beyond Baijiu, A Cultural Encounter20.11.2026 16:05:00 CET | Press release

On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120301288/en/ On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. As the world’s first Moutai brand experience space built under its new SI standards, this three-storey venue brings together cultural exhibitions, baijiu tasting, distinctive dining and creative cocktails. Using Moutai as a bridge, it creates new opportunities for Chinese baijiu culture to blend with and draw inspiration from Singapore’s diverse lifestyle and cultural scene. As early as 1954, Guizhou Moutai arrived in Singapore via the Singapore River, marking its first entry into Southeast Asia, right across from Fullerton Waterboat House. 72 years later, Moutai House has found its home along the same riverbank, transforming a historic arrival into a lasting presence and turning a con

ViTAA Medical and The Society for Vascular Surgery Announce Strategic Partnership20.11.2026 15:00:00 CET | Press release

ViTAA Medical to Become Key SVS AI Partner, Advancing AI Education and Responsible Adoption in Vascular Care ViTAA Medical Solutions Inc. (ViTAA) today announced a strategic partnership with The Society for Vascular Surgery (SVS) to advance evidence, education, and the responsible adoption of quantitative imaging and artificial intelligence in vascular care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120954362/en/ The partnership will support evidence building, best practices, educational resources for SVS members, physicians and trainees on AI validation, interpretation, and clinical limitations. The relationship has the potential to pave the way for additional AI tools and resources for SVS members through the Society in the future. The partnership creates a framework for the organizations to lead AI-enabled research opportunities involving imaging and clinical outcomes. Mitchel Benovoy, PhD, Chief Executive Officer

Epitech Group and Horus Pharma sign a global licensing agreement to develop adelmidrol in eye health20.11.2026 14:39:00 CET | Press release

Epitech Group S.p.A., an Italian biopharmaceutical firm specializing in neuro-inflammation, and Horus Pharma, a French laboratory specializing in ophthalmology, announce a global licensing agreement for adelmidrol, a molecule belonging to the ALIAmide family, developed by Epitech Group. This agreement grants Horus Pharma exclusive rights to develop and market adelmidrol for human ophthalmology and periocular dermatology applications. It aims to explore new approaches to address unmet medical needs in eye health. A combination of complementary scientific expertise Epitech Group has been studying ALIAmides and their role in physiological regulatory mechanisms for over 30 years, building on the research of Rita Levi-Montalcini, the 1986 Nobel Prize in Medicine laureate who first identified the ALIA mechanism. Horus Pharma, for its part, contributes over 20 years of ophthalmology expertise, strong R&D capabilities, and its international presence. Against the backdrop of an aging population

Adyen Merchants Can Now Offer Klarna in AI Agent Checkout20.11.2026 14:30:00 CET | Press release

Klarna is Adyen’s first non-card, local payment method for agentic commerce Klarna (NYSE: KLAR), the everyday finance network, and Adyen (AMS: ADYEN) today announced that shoppers can now pay with Klarna when an AI agent checks out for them through Adyen Agentic. Klarna is the first payment option beyond cards available in Adyen Agentic, Adyen’s agentic commerce suite, and merchants that already offer Klarna through Adyen can switch it on with no new integration work. Today, most AI shopping agents complete purchases with a stored credit or debit card, leaving out flexible payment options that many shoppers choose at regular checkout. With Klarna now a payment method within Adyen Agentic, the agent shows shoppers the same Klarna options the merchant already offers, such as paying in full, in interest-free installments or with financing. Shoppers review and confirm every purchase before it is completed. Adyen built the integration on Klarna’s open payment handler, a published specificat

SatSure Raises Series B to Scale Its Full-Stack Earth Intelligence Platform for Global Markets20.11.2026 11:05:00 CET | Press release

India’s sovereign space-technology fund leads the first close of the ongoing INR 200 crore (c. USD 21 million) round SatSure, a global Earth intelligence company headquartered in India, today announced the first close of its ongoing INR 200 crore (c. USD 21 million) Series B round. The round is led by a INR 60 crore (c. USD 6.4 million) investment from the Antariksh Venture Capital Fund (AVCF), India’s sovereign space-technology fund, anchored by the national space regulator IN-SPACe and managed by SIDBI Venture Capital Limited. The investment marks AVCF’s first deployment into the downstream data and AI layer of India’s space economy, extending the fund beyond upstream launch and satellite hardware into commercial space-data infrastructure capable of serving global enterprise and sovereign markets. The round comprises INR 165 crore (c. USD 17.6 million) in equity, INR 25 crore (c. USD 2.7 million) in venture debt and INR 10 crore (c. USD 1.1 million) in secondary transactions, closing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye